Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN, TANER; Buyukhatipoglu, Hakan; Balakan, Ozan; KERTMEN, NEYRAN; Suner, Ali; Sarici, Furkan; AKIN, SERKAN; ATEŞ, ÖZTÜRK; Karakas, Yusuf; Aslan, Alma; DIKER, OMER; Altundag, Kadri

Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

Atıf İçin Kopyala

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., ...Daha Fazla

JOURNAL OF BUON, cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 2
Basım Tarihi: 2015
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.479-486
Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: In lymph node-negative, hormone-positive, and Her2-negative breast cancer patients, the benefits of adding adjuvant chemotherapy to hormonal therapy continue to be debated, especially for low to intermediate grade and small tumors.